Reports

NVIDIA delivered a record-breaking Q4 FY25 with revenue reaching $39.3 billion, up 12% sequentially and 78% year-over-year. Data Center revenue surged to $35.6 billion, a 93% YoY increase. The company achieved a GAAP net income of $22.1 billion and an operating income of $24.0 billion. Non-GAAP EPS stood at $0.89 per share, reflecting strong demand for AI computing solutions. The outlook for Q1 FY26 remains positive, with expected revenue of $43.0 billion.

• Record quarterly revenue of $39.3 billion, up 78% YoY.
• Data Center revenue surged to $35.6 billion, growing 93% YoY.

Salesforce delivered solid financial results in Q4 FY25, reporting $10.0 billion in revenue, an 8% year-over-year increase. Non-GAAP EPS reached $2.78, reflecting strong operational execution. The company achieved a GAAP operating margin of 18.2% and a non-GAAP operating margin of 33.1%. Net income totaled $1.71 billion, and free cash flow stood at $3.82 billion. The company remains well-positioned for FY26 with continued growth in Data Cloud and AI-related offerings.

• Revenue grew 8% YoY to $10.0 billion, driven by subscription and support revenue.
• Non-GAAP EPS increased to $2.78, outperforming expectations.

Lowe's reported Q4 2024 revenue of $18.55 billion, net income of $1.13 billion, and diluted EPS of $1.99. Adjusted diluted EPS for the quarter was $1.93. The company saw a 0.2% increase in comparable sales driven by Pro and online sales.

• Reported revenue of $18.55 billion for Q4 2024.
• Net income for the quarter was $1.13 billion.

TJX Companies reported Q4 2025 results with a 5% increase in consolidated comparable store sales and diluted EPS of $1.23, surpassing expectations. The company plans to increase its dividend by 13% and repurchase $2.0 to $2.5 billion of stock in FY26.

• Consolidated comparable store sales increased 5%, driven by higher customer transactions.
• Pretax profit margin reached 11.6%, exceeding the company's plan.

Anheuser-Busch InBev reported Q4 2024 revenue of $14.84 billion and underlying profit of $1.77 billion. Underlying EPS increased to $0.88. Revenue growth was driven by strong performance in EMEA and South America despite volume declines in China and North America.

• Revenue increased by 3.4% to $14.84 billion.
• Underlying profit for Q4 2024 was $1.77 billion.

Synopsys delivered solid financial results for Q1 FY25, with revenue of $1.455 billion, reflecting a slight decline from the prior year. GAAP EPS was $1.89, while non-GAAP EPS exceeded expectations at $3.03. The company achieved an operating income of $251.8 million. Free cash flow guidance for the full fiscal year remains strong at approximately $1.6 billion, reaffirming expectations for double-digit revenue growth.

• Revenue for Q1 FY25 was $1.455 billion, slightly lower than Q1 FY24.
• GAAP EPS came in at $1.89, while non-GAAP EPS exceeded expectations at $3.03.

Snowflake delivered solid financial results in Q4 FY25, with revenue reaching $986.8 million, reflecting a 27% year-over-year increase. Product revenue stood at $943.3 million, growing 28% YoY. Despite a GAAP operating loss of $386.7 million, the company achieved a non-GAAP operating income of $92.8 million. Free cash flow was strong at $415.4 million, highlighting Snowflake’s ability to generate significant cash from operations.

• Revenue grew 27% YoY to $986.8 million, driven by strong product adoption.
• Non-GAAP operating income reached $92.8 million, showing improved profitability.

CRH achieved Q4 2024 revenue of $8.9 billion, a 2% increase year-over-year. Net income rose by 24% to $0.7 billion, with an 8.0% net income margin. Adjusted EBITDA was $1.8 billion, up 12%, supported by pricing improvements and operational efficiencies. EPS reached $1.03, a 4% increase, while pre-impairment EPS stood at $1.45, up 12%.

• Q4 revenue reached $8.9 billion, increasing 2% year-over-year.
• Net income rose by 24% to $0.7 billion, with an 8.0% margin.

Petrobras reported a net loss of $2.78 billion in Q4 2024 due to exchange rate fluctuations impacting debt. The company's revenue fell 23.2% YoY to $20.82 billion. Operating income was $2.79 billion, while free cash flow for the quarter stood at $3.77 billion. Adjusted EBITDA was $7.17 billion, with significant contributions from the exploration and production segment.

• Revenue declined 23.2% YoY to $20.82 billion, impacted by lower oil prices and refining margins.
• Net loss of $2.78 billion due to foreign exchange losses, while net income without one-off events was $3.1 billion.

Agilent Technologies posted Q1 2025 revenue of $1.68 billion, a 1.4% increase year-over-year. GAAP net income was $318 million, with EPS of $1.11, down 6% from last year. Non-GAAP EPS came in at $1.31, a 2% rise. The company reaffirmed its core growth and EPS expectations for the year.

• Revenue reached $1.68 billion, growing 1.4% year-over-year.
• GAAP EPS was $1.11, down from $1.18 in Q1 2024.

Verisk reported consolidated revenue of $736 million for Q4 2024, reflecting an 8.6% increase year-over-year. The company achieved a net income of $210.4 million and an EPS of $1.44. Diluted adjusted EPS was $1.61, driven by growth in underwriting and claims segments.

• Consolidated revenue increased by 8.6% year-over-year to $736 million.
• Net income for the quarter was $210.4 million.

HEICO Corporation reported Q1 2025 revenue of $1.03 billion, a 15% increase year-over-year. Net income rose 46% to $168.0 million, with EPS reaching $1.20 per diluted share. Operating income climbed 26% to $226.8 million, driven by strong demand across its Flight Support and Electronic Technologies segments. The company maintained strong cash flow, executing acquisitions while keeping leverage stable.

• Revenue increased 15% to $1.03 billion.
• Net income surged 46% to $168.0 million.

eBay delivered steady financial performance in Q4 2024, with revenue reaching $2.6 billion, reflecting a 1% year-over-year increase. GMV rose to $19.3 billion, up 4% YoY, driven by strong marketplace activity. The company posted GAAP EPS of $1.40 and Non-GAAP EPS of $1.25. Free cash flow stood at $560 million. eBay returned $1.0 billion to shareholders through buybacks and dividends while expanding its AI-powered listing tools and payment options.

• Revenue grew 1% YoY to $2.6 billion, meeting expectations.
• GMV increased 4% YoY to $19.3 billion, marking three consecutive quarters of growth.

Ambev reported Q4 2024 revenue of R$27.04 billion, net income of R$5.02 billion, and normalized EBITDA of R$9.62 billion. Normalized EPS was R$0.31, reflecting a 7.8% increase compared to the same period in 2023. Strong revenue growth was driven by positive performances in Brazil NAB and Central America and the Caribbean.

• Revenue increased by 4.2% to R$27.04 billion.
• Net income for Q4 2024 was R$5.02 billion.

FirstEnergy posted Q4 2024 GAAP earnings of $261 million, or $0.45 per share, on revenue of $3.2 billion. Non-GAAP operating earnings came in at $0.67 per share, while Core EPS stood at $0.61 per share. The company benefited from higher revenue driven by rate base growth and cost efficiencies, but faced some headwinds from tax rates and lower Ohio distribution revenues.

• Q4 2024 GAAP earnings were $261 million ($0.45 per share), up from $175 million ($0.30 per share) in Q4 2023.
• Operating (Non-GAAP) EPS increased to $0.67 per share from $0.62 per share in Q4 2023.

Expand Energy reported a Q4 2024 net loss of $399 million ($1.72 per share), while adjusted net income reached $131 million ($0.55 per share). Revenue totaled $2.001 billion, driven by strong production of 6.41 Bcfe/d. The company continues to invest in expansion and efficiency improvements despite market challenges.

• Q4 2024 revenue increased to $2.001 billion, up from $1.948 billion in Q4 2023.
• Net loss for Q4 2024 was $399 million, compared to a net income of $569 million in Q4 2023.

Pure Storage reported Q4 2025 revenue of $879.8 million, an 11% increase year-over-year, driven by strong subscription services growth. GAAP net income was $42.4 million, with non-GAAP operating income reaching $153.1 million. The company continues to scale its subscription model, with ARR reaching $1.7 billion, up 21% year-over-year.

• Q4 2025 revenue reached $879.8 million, up 11% year-over-year.
• GAAP net income was $42.4 million, while non-GAAP operating income stood at $153.1 million.

Golden Ocean Group reported Q4 2024 revenue of $210.97 million and net income of $39.0 million. Adjusted net income was $12.7 million, and adjusted EBITDA was $69.9 million. Earnings per share for the quarter were $0.20, while adjusted EPS was $0.06. The company also announced a cash dividend of $0.15 per share.

• Reported Q4 2024 revenue of $210.97 million.
• Net income for the quarter was $39.0 million.

NRG Energy, Inc. reported GAAP net income of $643 million for Q4 2024 with an adjusted EPS of $1.56, reflecting strong operational performance. The company achieved an adjusted EBITDA of $902 million, despite the impact of extended planned maintenance and the sale of certain assets. Revenues for the quarter amounted to $6.86 billion.

• GAAP net income of $643 million for Q4 2024.
• Adjusted EPS of $1.56 for Q4 2024.

AerCap reported net income of $671 million and adjusted net income of $624 million for Q4 2024, with total revenues and other income increasing by 9% to $2.07 billion.

• Net income of $671 million, or $3.56 per share, for Q4 2024.
• Adjusted net income of $624 million, or $3.31 per share, for Q4 2024.

Invitation Homes delivered a 5.6% year-over-year revenue increase in Q4 2024, reaching $659 million. Net income totaled $143 million, or $0.23 per share, while Core FFO per share grew by 5.9% to $0.47. Average monthly rent increased by 3.1%, and occupancy remained strong at 96.7%. The company continued expanding its portfolio, acquiring 501 homes during the quarter.

• Q4 2024 revenue increased 5.6% year-over-year to $659 million.
• Net income for Q4 2024 was $143 million ($0.23 per share), up from $129 million in Q4 2023.

Nutanix reported Q2 2025 revenue of $654.7 million, a 16% year-over-year increase. The company achieved a net income of $56.4 million and a non-GAAP EPS of $0.56. ARR grew 19% year-over-year to $2.06 billion, while free cash flow improved to $187.1 million. The company's continued momentum reflects strong demand for its hybrid multicloud solutions and strategic partnerships.

• Q2 2025 revenue increased 16% year-over-year to $654.7 million.
• Net income rose to $56.4 million, up from $32.8 million in Q2 2024.

Sun Communities, Inc. reported a net loss of $224.4 million for Q4 2024, driven by impairment charges and hurricane-related expenses. However, Core FFO per share increased to $1.41, and North American same-property NOI grew by 5.7%. The company completed key dispositions, including the planned sale of its marina segment for $5.65 billion, to focus on its core businesses and reduce leverage.

• Net loss of $224.4 million in Q4 2024 due to impairment charges and hurricane-related costs.
• Core FFO per share increased to $1.41 from $1.34 in Q4 2023.

United Therapeutics reported Q4 2024 revenue of $735.9 million, driven by significant growth in Tyvaso and Orenitram. The company achieved net income of $301.3 million and an EPS of $6.74. Adjusted EPS was $6.19. Strong performance across key product lines contributed to a robust quarter.

• Total revenue for Q4 2024 was $735.9 million, up 20% from Q4 2023.
• Net income for the quarter was $301.3 million.

Western Midstream Partners, LP reported Q4 2024 net income of $325.9 million and Adjusted EBITDA of $590.7 million. Natural gas, crude oil, and produced water throughput saw sequential growth. The company generated $309.3 million in free cash flow and maintained a strong balance sheet while executing its capital return strategy.

• Net income of $325.9 million and Adjusted EBITDA of $590.7 million in Q4 2024.
• Generated $309.3 million in free cash flow, supporting capital return strategy.

Morningstar, Inc. reported a 9.7% increase in Q4 2024 revenue to $591.0 million, with adjusted EPS growing 8.6% to $2.14. Operating income rose 78.2% to $168.2 million, driven by the sale of US TAMP assets. Free cash flow improved to $112.8 million. PitchBook and Morningstar Credit led revenue growth, supported by higher demand for investment insights and analytics.

• Revenue grew 9.7% year-over-year to $591.0 million, with organic revenue increasing 10.6%.
• Operating income surged 78.2% to $168.2 million, benefiting from a $64.0 million asset sale gain.

Bentley Systems reported total revenues of $349.8 million for Q4 2024, a 12.6% increase year-over-year. The company achieved an adjusted EPS of $0.21 and an operating income margin of 17.6%. Subscription revenues drove growth, increasing by 15.8% compared to the prior year.

• Total revenues of $349.8 million, up 12.6% year-over-year.
• Adjusted EPS of $0.21, up from $0.20 in the same period last year.

Universal Health Services, Inc. reported Q4 2024 revenue of $4.11 billion, an increase of 11.1% year-over-year. Net income rose to $332.4 million, while adjusted EPS increased to $4.92. Revenue from acute care and behavioral health services grew by 8.7% and 11.1%, respectively. EBITDA net of NCI improved to $620.2 million, reflecting strong operational performance.

• Revenue increased 11.1% year-over-year to $4.11 billion.
• Net income rose 53.6% to $332.4 million, with adjusted EPS at $4.92.

Ovintiv reported strong fourth-quarter results, with Non-GAAP Free Cash Flow of $452 million and average quarterly production volumes of 580 MBOE/d. The company's financial performance was driven by a focus on value creation and execution excellence.

• Generated fourth quarter cash from operating activities of $1.0 billion and Non-GAAP Free Cash Flow of $452 million after capital expenditures of $552 million.
• Delivered average quarterly production volumes of 580 MBOE/d, including 210 Mbbls/d of oil and condensate, 90 Mbbls/d of other NGLs and 1,680 MMcf/d of natural gas.

Sarepta Therapeutics posted total revenue of $658.4 million in Q4 2024, a 66% increase year-over-year. The company achieved GAAP net income of $159.0 million and non-GAAP net income of $206.0 million. The growth was largely fueled by ELEVIDYS sales, which accounted for $384.2 million in revenue. Operating income improved significantly to $161.7 million.

• Q4 2024 total revenue reached $658.4 million, up 66% year-over-year.
• ELEVIDYS contributed $384.2 million in revenue, with an additional $4.9 million in royalties.

DT Midstream reported net income of $73 million for Q4 2024, with EPS of $0.73 and operating earnings of $94 million, or $0.94 per share. Adjusted EBITDA for the quarter was $235 million, reflecting continued success in organic growth projects and acquisitions.

• Net income for Q4 2024 was $73 million.
• EPS was reported at $0.73, with operating earnings of $0.94 per share.

Essential Utilities posted total revenue of $604.4 million in Q4 2024, marking a 26.1% increase year-over-year. The company achieved net income of $184.8 million and EPS of $0.67, reflecting a 34% increase compared to Q4 2023. Growth was driven by regulatory recoveries, increased water and natural gas volume, and successful rate adjustments.

• Q4 2024 revenue grew 26.1% year-over-year to $604.4 million.
• Net income reached $184.8 million, up from $135.5 million in Q4 2023.

FTAI Aviation delivered strong financial performance in Q4 2024, with revenue reaching $498.82 million and net income attributable to shareholders at $86.69 million. The company also reported an adjusted EBITDA of $252.02 million and declared a dividend of $0.30 per share.

• Revenue increased to $498.82 million in Q4 2024.
• Net income attributable to shareholders was $86.69 million.

APA Corporation reported Q4 2024 revenue of $2.71 billion and net income attributable to common stock of $354 million. Adjusted EBITDAX was $1.55 billion, and the company generated free cash flow of $420 million. The quarter saw a strong performance despite some operational challenges.

• Revenue reached $2.71 billion in Q4 2024.
• Net income attributable to common stock was $354 million.

Chemed Corporation reported Q4 2024 revenue of $640.0 million, an increase of 9.2% year-over-year. Net income attributable to common stock was $90.3 million, with EPS of $6.02 and adjusted EPS of $6.83. VITAS segment revenue grew 17.4%, while Roto-Rooter saw a slight revenue decline. Free cash flow remained strong, and the company repurchased shares worth $212.8 million.

• Revenue increased 9.2% to $640.0 million.
• Net income attributable to common stock was $90.3 million.

IonQ reported strong Q4 2024 results, surpassing revenue expectations with $11.7 million in revenue. The company posted a net loss of $202.0 million, with an adjusted EBITDA loss of $32.8 million. Cash, cash equivalents, and investments totaled $363.8 million. IonQ also secured a major partnership with the Air Force Research Lab and announced its acquisition of a majority stake in ID Quantique.

• Revenue of $11.7 million, exceeding the high end of guidance.
• Net loss of $202.0 million and adjusted EBITDA loss of $32.8 million.

ICL Group reported Q4 2024 revenue of $1.601 billion and net income of $70 million. Adjusted EBITDA for the quarter was $347 million. The Potash segment saw a decline in sales revenue, while Industrial Products performed well due to improved operational efficiencies.

• Reported Q4 2024 revenue of $1.601 billion, down from $1.690 billion in Q4 2023.
• Net income for the quarter was $70 million, up from $67 million in Q4 2023.

Paramount reported Q4 2024 revenue of $7.98 billion, a 5% increase year-over-year. However, the company faced a net loss of $224 million, with adjusted EPS at -$0.11. Revenue growth was driven by a 67% increase in Filmed Entertainment and an 8% increase in Direct-to-Consumer. Operating income declined by 68% to $129 million, impacted by restructuring and impairment charges.

• Revenue increased 5% year-over-year to $7.98 billion.
• Net loss of $224 million, compared to a $4 million profit in Q4 2023.

Revolution Medicines reported no revenue in Q4 2024, reflecting the termination of its Sanofi collaboration. The company posted a net loss of $194.6 million, driven by increased R&D expenses of $188.1 million. Cash, cash equivalents, and marketable securities reached $2.3 billion following an $823 million public equity offering. The company continues advancing its RAS(ON) inhibitors, with multiple Phase 3 trials underway.

• Net loss widened to $194.6 million from $161.5 million in Q4 2023.
• No revenue was reported, down from $742,000 in Q4 2023.

Lantheus reported worldwide revenue of $391.1 million for Q4 2024, a 10.5% increase compared to the same period in 2023. PYLARIFY achieved record net sales, but the company posted a GAAP net loss of $11.8 million for the quarter. Adjusted earnings per share were $1.59, reflecting continued growth in radiopharmaceuticals.

• Worldwide revenue of $391.1 million, up 10.5% year-over-year.
• GAAP net loss of $11.8 million for the quarter.

Madrigal Pharmaceuticals reported net revenue of $103.3 million for Q4 2024 driven by Rezdiffra sales. The company incurred a net loss of $59.4 million due to high operating expenses related to Rezdiffra's commercial launch. Cost of sales was reported at $3.4 million for the quarter.

• Net revenue of $103.3 million driven by Rezdiffra sales.
• Net loss of $59.4 million for Q4 2024.

APi Group achieved record results for Q4 2024, with net revenues of $1.86 billion and a 16.3% increase in adjusted EBITDA. Net income grew by 168% year-over-year to $67 million. Adjusted diluted EPS was $0.51, up 15.9% compared to the prior year period.

• Record net revenues of $1.86 billion, up 5.8% year-over-year.
• Adjusted EBITDA increased by 16.3% to $242 million.

Corcept Therapeutics posted Q4 2024 revenue of $181.9 million, a 34% increase year-over-year. However, net income slightly declined to $30.7 million, driven by higher research and development (R&D) expenses. The company remains financially strong with $603.2 million in cash and investments, supporting ongoing clinical programs. Corcept continues to advance its cortisol modulation therapies, with an NDA submitted for relacorilant and promising oncology and metabolic trials underway.

• Revenue increased 34% year-over-year to $181.9 million.
• Net income declined slightly to $30.7 million from $31.4 million in Q4 2023.

Joby Aviation reported a Q4 2024 net loss of $246.3 million, primarily due to increased operating expenses related to aircraft certification and manufacturing. The company ended the quarter with $932.9 million in cash, cash equivalents, and short-term investments, supplemented by public offerings. Joby made significant progress on FAA certification, delivered a second aircraft to the U.S. Air Force, and began construction of its first Dubai vertiport.

• Net loss widened to $246.3 million, up from $115.1 million in Q4 2023.
• Operating loss reached $149.9 million, reflecting investments in certification and manufacturing.

Marathon Digital Holdings achieved record-high revenue, net income, and Adjusted EBITDA in Q4 2024. Revenues increased 37% year-over-year to $214.4 million, net income surged 248% to $528.3 million, and Adjusted EBITDA grew 207% to $794.4 million. The company's strategic shift to a vertically integrated energy and digital infrastructure model, coupled with significant acquisitions and operational improvements, contributed to these strong results.

• Record-high revenue of $214.4 million in Q4 2024, a 37% increase from Q4 2023.
• Net income increased 248% to $528.3 million in Q4 2024, with diluted EPS of $1.24.

Federal Signal reported a record Q4 2024 with a 5% increase in net sales, 11% rise in operating income, and 18% growth in adjusted EPS compared to the prior year.

• Net sales increased by 5% to $472 million.
• Operating income rose by 11% to $70.1 million.

Southwest Gas delivered strong performance in Q4 2024, with a 34% increase in net income driven by higher operating margin and improved cost management.

• Net income increased to $92.5 million, up from $72.9 million in Q4 2023.
• Adjusted EPS increased to $1.39, up from $1.20 in Q4 2023.

Option Care Health delivered solid financial results in Q4 2024 with net revenue growth of 19.7%, increased net income, and a higher adjusted EBITDA, demonstrating resilience in a dynamic market environment.

• Net revenue increased by 19.7% to $1.35 billion.
• Net income rose to $60.1 million, up from $57.2 million in Q4 2023.

Dycom achieved significant growth in Q4 2025 with contract revenues up 13.9% year-over-year, improved profitability, and a higher adjusted EBITDA. The company's net income increased by 39.6% compared to the same period last year.

• Contract revenues increased by 13.9% to $1.085 billion.
• Adjusted EBITDA grew by 24.2% to $116.4 million.

Macerich reported total revenue of $273.7 million in Q4 2024. However, the company faced a significant net loss of $211.2 million, primarily due to asset write-downs. Same-center net operating income (NOI) declined 0.4% year-over-year. Portfolio occupancy improved slightly to 94.1%, while re-leasing spreads remained positive. The company announced a quarterly dividend of $0.17 per share.

• Total revenue reached $273.7 million, up from $238.7 million in Q4 2023.
• Net loss of $211.2 million, mainly driven by asset impairments.

Kratos Defense & Security Solutions posted Q4 2024 revenue of $283.1 million, reflecting a 3.4% growth year-over-year. The company achieved a net income of $3.9 million and an adjusted EPS of $0.13. Free cash flow for the quarter was $32.0 million, and the book-to-bill ratio stood at 1.5 to 1. Revenue growth was driven by strong performance in Unmanned Systems and Government Solutions, partially offset by declines in Space and Satellite businesses.

• Revenue grew 3.4% year-over-year to $283.1 million.
• Net income rose to $3.9 million from $2.4 million in Q4 2023.

Urban Outfitters, Inc. achieved record Q4 2025 revenue of $1.64 billion, reflecting a 10.1% year-over-year increase. Net income for the quarter was $120.3 million, with an adjusted EPS of $1.04. Growth was driven by strong sales in the Anthropologie and Free People brands, while Urban Outfitters experienced a decline. The Nuuly subscription business continued to expand, with a 78.4% revenue increase.

• Revenue reached a record $1.64 billion, up 10.1% year-over-year.
• Net income increased to $120.3 million from $47.8 million in Q4 2024.

Icahn Enterprises reported a net loss of $98 million for Q4 2024, an improvement compared to a net loss of $139 million in Q4 2023. Revenue decreased slightly to $2.6 billion, while Adjusted EBITDA rose to $12 million.

• Net loss improved to $98 million, compared to a loss of $139 million in Q4 2023.
• Revenue for Q4 2024 was $2.6 billion, a decrease from Q4 2023 revenue of $2.7 billion.

CBIZ reported Q4 2024 revenue of $460.3 million, driven by a 40.5% increase compared to Q4 2023. The increase was primarily attributed to the Marcum acquisition. The company reported a net loss of $90.7 million, with adjusted net loss of $10.1 million and adjusted diluted EPS of -$0.20.

• Revenue increased 40.5% to $460.3 million in Q4 2024.
• Net loss for Q4 2024 was $90.7 million.

Cactus, Inc. posted Q4 2024 revenue of $272.1 million, slightly down from Q4 2023. Net income was $57.4 million, and adjusted EPS stood at $0.71. While Pressure Control revenues declined due to lower customer activity, the Spoolable Technologies segment faced seasonal slowdowns. Despite revenue pressures, the company maintained strong operating margins and continued to generate positive cash flow.

• Revenue of $272.1 million, a 1% decline from Q4 2023.
• Net income of $57.4 million, with a 21.1% net income margin.

Brink's delivered strong performance in Q4 2024 with record revenue, continued organic growth, and robust operating profitability. The company recorded net income of $39 million, and operating profit margin reached 8.3%.

• Revenue increased by 1% to $1.264 billion.
• Adjusted EBITDA totaled $251 million.

Dorman Products delivered a solid Q4 2024, with revenue increasing 8.0% year-over-year to $533.8 million. Net income was $54.5 million, and adjusted EPS grew 40% to $2.20. The Light Duty and Specialty Vehicle segments drove growth, while the Heavy Duty segment saw a decline. The company generated $71 million in operating cash flow and repaid $54 million in debt.

• Revenue increased 8.0% year-over-year to $533.8 million.
• Net income rose to $54.5 million, with a 10.2% net income margin.

C3.ai posted Q3 2025 revenue of $98.8 million, a 26% increase year-over-year, driven by growth in subscription and professional services revenue. However, the company reported a net loss of $80.2 million, with an adjusted net loss per share of $0.12. Despite the losses, C3.ai expanded its strategic partnerships and grew its contract pipeline significantly.

• Revenue grew 26% year-over-year to $98.8 million.
• Subscription revenue rose 22% to $85.7 million, comprising 87% of total revenue.

Graham Holdings Company reported a 7% increase in fourth-quarter revenue to $1,245.8 million and a substantial rise in net income attributable to common shares to $548.8 million, up from $53.3 million in the prior year. This growth was primarily driven by strong performance in education, television broadcasting, and healthcare segments.

• Fourth-quarter 2024 revenue increased 7% to $1,245.8 million, up from $1,166.8 million in 2023.
• Net income attributable to common shares for Q4 2024 was $548.8 million ($125.55 per share), significantly higher than $53.3 million ($11.72 per share) in Q4 2023.

Ormat Technologies reported Q4 2024 revenue of $230.7 million, a 4.4% decline year-over-year, primarily due to lower electricity and product segment revenue. Net income increased by 14.3% to $40.8 million, with adjusted EPS rising to $0.72. Energy storage revenue grew significantly by 56.7%, reflecting the company's strategic focus on expanding capacity.

• Total revenue decreased 4.4% year-over-year to $230.7 million.
• Net income rose 14.3% to $40.8 million, driven by improved cost efficiencies.

EPR Properties posted Q4 2024 revenue of $177.2 million, a 3.0% increase year-over-year. However, the company reported a net loss of $14.4 million, primarily due to impairment charges related to theatre and education investments. Adjusted Funds From Operations (AFFO) per diluted share increased to $1.22. The company continued its capital recycling strategy, reinvesting in experiential properties while exiting underperforming assets.

• Total revenue increased 3.0% year-over-year to $177.2 million.
• Net loss of $14.4 million due to impairment charges on non-core assets.

Kinetik Holdings Inc. posted Q4 2024 revenue of $385.7 million, reflecting an increase from the prior year. The company generated net income of $16.2 million and an adjusted EPS of $0.01. Adjusted EBITDA for the quarter stood at $237.5 million, with free cash flow of $32.5 million. The company faced temporary setbacks due to gas price volatility but remains on track for long-term growth, supported by strategic acquisitions and infrastructure expansion.

• Total revenue increased to $385.7 million in Q4 2024.
• Net income stood at $16.2 million, with adjusted EPS of $0.01.

Greif posted Q1 2025 revenue of $1.27 billion, reflecting a 5.0% increase year-over-year. However, net income declined 87.2% to $8.6 million due to a prior-year tax benefit. Adjusted EBITDA rose 5.9% to $145.1 million, supported by strong performance in the Sustainable Fiber Solutions segment. The company continues restructuring efforts, including divestitures and mill closures, to optimize its portfolio and reduce costs.

• Revenue grew 5.0% year-over-year to $1.27 billion.
• Net income declined 87.2% to $8.6 million due to a prior-year tax benefit.

Sweetgreen posted Q4 2024 revenue of $160.9 million, reflecting a 5% year-over-year increase. The company reported a net loss of $29.0 million and an adjusted EBITDA loss of $0.6 million. Same-store sales growth slowed to 4% compared to 6% in the prior year. Digital revenue remained a significant portion of total sales, with 56% of revenue coming from digital channels.

• Total revenue increased 5% year-over-year to $160.9 million.
• Net loss widened to $29.0 million, with a loss from operations margin of 20%.

Rhythm Pharmaceuticals reported solid growth in global sales of IMCIVREE during Q4 2024, driven by treatment of Bardet-Biedl syndrome. The company also raised $75 million in gross proceeds under its ATM equity offering program, extending its cash runway into 2027.

• Q4 2024 net revenue from IMCIVREE sales was $41.8 million, a 26% increase sequentially.
• U.S. revenue accounted for 76% of product sales, increasing 36.2% sequentially.

Marriott Vacations Worldwide Corporation reported a strong end to 2024, with consolidated vacation ownership contract sales increasing by 7% to $477 million in the fourth quarter. The company achieved a net income attributable to common stockholders of $50 million and adjusted diluted earnings per share of $1.86.

• Consolidated Vacation Ownership contract sales increased 7% to $477 million in Q4 2024, including 9% first-time buyer contract sales growth.
• Net income attributable to common stockholders was $50 million, with diluted earnings per share at $1.30.

Ambarella, an edge AI semiconductor company, announced robust financial results for the fourth quarter and full fiscal year 2025. Revenue for Q4 2025 increased by 62.8% year-over-year to $84.0 million, and the company achieved a non-GAAP net profit of $4.8 million, a significant improvement from a net loss in the prior year. The company also reported that over 70% of its total revenue came from edge AI, marking a quarterly and annual record.

• Fourth quarter fiscal 2025 revenue was $84.0 million, a 62.8% increase from the same period in fiscal 2024.
• Non-GAAP net profit for Q4 2025 was $4.8 million, or $0.11 per diluted ordinary share, compared to a net loss in the prior year.

Acadia Pharmaceuticals closed 2024 with record revenues for both NUPLAZID and DAYBUE in the fourth quarter, contributing to a 32% revenue growth for the full year. The company reported a net income of $143.7 million for Q4 2024, a significant increase from the previous year, and provided strong revenue guidance for 2025.

• Total revenues for the fourth quarter of 2024 were $259.6 million.
• Net income for the fourth quarter of 2024 was $143.7 million, or $0.86 per common share.

Amedisys reported a net service revenue increase to $598.1 million in Q4 2024, up from $570.8 million in Q4 2023. However, the company experienced a net loss attributable to Amedisys, Inc. of $20.4 million, or $0.62 per diluted share, primarily due to merger-related expenses and a non-cash goodwill and other intangibles impairment charge.

• Net service revenue increased by $27.3 million to $598.1 million in Q4 2024.
• The company reported a net loss attributable to Amedisys, Inc. of $20.4 million in Q4 2024, compared to a net income of $19.3 million in Q4 2023.

Steve Madden announced its Q4 and full year 2024 results, with revenue increasing 15% and Adjusted diluted EPS increasing 9% for the year. The company is cautious on the near-term outlook due to new tariffs but anticipates growth with the pending acquisition of Kurt Geiger.

• Revenue for the wholesale business increased by 13.6% compared to Q4 2023.
• Wholesale footwear revenue increased by 1.0%, while wholesale accessories/apparel revenue increased by 35.4%.

Crescent Energy reported a net loss of $170 million for the fourth quarter of 2024, with total revenues reaching $875.289 million. The company achieved record annual production of 201 MBoe/d, a 30% increase year-over-year, driven by acquired volumes and increased well productivity. They also generated $1.2 billion in Operating Cash Flow and $630 million in Levered Free Cash Flow for the full year.

• Achieved record annual production of 201 MBoe/d, a greater than 30% increase year-over-year.
• Generated $1.2 billion in Operating Cash Flow and $630 million in Levered Free Cash Flow for the full year.

Avista Corp. reported consolidated earnings per diluted share of $2.29 for the full year of 2024. The company initiated consolidated guidance of $2.52 to $2.72 per share for 2025.

• Consolidated earnings per diluted share of $2.29 for the full year of 2024.
• Utility operations led continued improvement in consolidated earnings.

National Storage Affiliates Trust reported a net income of $26.1 million for Q4 2024, a significant decrease of 75.8% compared to Q4 2023. Diluted earnings per share were $0.15, down from $0.72 in the prior year. Core FFO per share was $0.60, an 11.8% decrease. The decline was mainly driven by a 7.5% decrease in same store net operating income, a 4.3% decrease in same store total revenues, and a 4.7% increase in same store property operating expenses.

• Net income for Q4 2024 was $26.1 million, a 75.8% decrease from Q4 2023.
• Diluted earnings per share for Q4 2024 were $0.15, down from $0.72 in Q4 2023.

The St. Joe Company announced a robust fourth quarter for 2024, with net income attributable to the Company increasing by 43% to $18.9 million and total revenue growing by 20% to $104.3 million. The company also achieved a record 331 homesite closings, an 82% increase year-over-year, and declared a quarterly dividend of $0.14 per share.

• Net income attributable to the Company increased by 43% to $18.9 million in Q4 2024.
• Total revenue grew by 20% to $104.3 million in Q4 2024, driven by strong performance across all segments.

United Parks & Resorts Inc. reported a decrease in both attendance and total revenue for the fourth quarter of 2024. Despite the decrease in attendance, total revenue per capita increased due to higher in-park spending.

• Attendance was 4.9 million guests, a decrease of approximately 79,000 guests from the fourth quarter of 2023.
• Total revenue was $384.4 million, a decrease of $4.6 million or 1.2% from the fourth quarter of 2023.

Chesapeake Utilities Corporation reported strong financial results for the fourth quarter of 2024, with net income increasing to $36.7 million and operating income rising to $66.9 million. Adjusted EPS for the quarter was $1.63. The company's performance was significantly boosted by the acquisition of Florida City Gas and various regulatory and infrastructure initiatives.

• Net income for Q4 2024 was $36.7 million, up from $25.3 million in Q4 2023.
• Adjusted EPS for Q4 2024 was $1.63, compared to $1.64 in Q4 2023.

Green Brick Partners, Inc. achieved record results in Q4 2024, with total revenues reaching $567.3 million, diluted EPS of $2.31, and 1,019 new homes delivered. The company also reported a record full-year diluted EPS of $8.45 and total revenues of $2.1 billion, driven by strong homebuilding gross margins and strategic land positions.

• Record Q4 home closings revenue of $557 million, up 24.2% year-over-year.
• Diluted EPS of $2.31 for Q4, a record for any fourth quarter, up 46.2% year-over-year.

Catalyst Pharmaceuticals achieved record fourth quarter and full year 2024 financial results, with total revenues reaching $141.8 million for Q4 and $491.7 million for the full year, driven by sustained organic growth of FIRDAPSE and the successful market adoption of AGAMREE.

• Total revenues for Q4 2024 increased by 28.3% year-over-year to $141.8 million.
• GAAP net income for Q4 2024 was $55.9 million, a 60.5% increase from the prior year.

Enovis reported a 23% increase in fourth-quarter net sales to $561 million, driven by strong growth in Global Reconstructive. However, the company reported a net loss of $704 million due to a $645 million non-cash goodwill impairment charge. Adjusted EBITDA increased to $113 million, representing 20% of sales.

• Fourth-quarter sales grew 23% on a reported basis.
• Reconstructive sales increased by 59% year-over-year.

FS KKR Capital Corp. reported a net investment income of $0.61 per share for Q4 2024, with total net realized and unrealized loss of $0.09 per share. The company's net asset value was $23.64 per share, and total purchases were $891 million.

• Net investment income for Q4 2024 was $0.61 per share, a decrease from $0.77 per share in the prior quarter.
• Adjusted net investment income for Q4 2024 was $0.66 per share.

Albany International reported a challenging fourth quarter of 2024 with net revenues down 11.3% and gross profit decreasing by 24.6% compared to the prior year. Adjusted EBITDA saw a substantial 33.4% decline. Despite this, the company generated strong free cash flow and re-initiated its share repurchase program, authorizing a new $250 million program.

• Net revenues for Q4 2024 were $286.9 million, an 11.3% decrease from the prior year.
• Gross profit for Q4 2024 was $90.3 million, down 24.6% compared to Q4 2023.

NewAmsterdam Pharma reported a net loss of $241.6 million for the full year 2024, an increase from $176.9 million in 2023. The company's revenue increased to $45.6 million in 2024 from $14.1 million in 2023, primarily due to a clinical success milestone and development cost reimbursement. Cash and cash equivalents significantly increased to $771.7 million by year-end 2024, driven by successful financing rounds.

• NewAmsterdam Pharma reported a full-year 2024 net loss of $241.6 million, compared to $176.9 million in 2023.
• Full-year 2024 revenue increased to $45.6 million from $14.1 million in 2023, driven by a clinical success milestone and development cost reimbursement.

Tandem Diabetes Care achieved record sales in Q4 2024, with worldwide GAAP sales growing 44% to $282.6 million and worldwide non-GAAP sales growing 21% to $252.4 million. The company also saw a more than 25% increase in worldwide pump shipments and a return to positive free cash flow for the full year.

• Worldwide GAAP sales increased by 44% to $282.6 million in Q4 2024 compared to Q4 2023.
• Worldwide non-GAAP sales grew by 21% to $252.4 million in Q4 2024 compared to Q4 2023.

Semrush Holdings, Inc. announced robust financial results for the fourth quarter and full year ended December 31, 2024, with Q4 revenue up 23% year-over-year to $102.6 million and full year revenue up 22% to $376.8 million. The company also reported a significant increase in non-GAAP operating income and free cash flow, alongside a leadership transition with William R. Wagner named as the new CEO and co-founder Oleg Shchegolev transitioning to CTO.

• Fourth quarter revenue increased by 23% year-over-year to $102.6 million.
• Non-GAAP income from operations for Q4 was $11.8 million, up from $8.3 million in the prior year period.

Atlanta Braves Holdings reported a total revenue of $52.118 million in the fourth quarter of 2024, a decrease from $67.748 million in the prior year period. The company experienced a net loss of $19.125 million for the quarter. Mixed-use development revenue increased by 21%, while baseball revenue decreased by 35% for the quarter.

• Total revenue for Q4 2024 was $52.118 million, a 23% decrease from Q4 2023.
• Baseball revenue decreased by 35% to $34.197 million in Q4 2024.

Magnite reported a strong fourth quarter in 2024, with total revenue increasing by 4% and Contribution ex-TAC up by 9% year-over-year. CTV Contribution ex-TAC saw significant growth of 23%, exceeding guidance. The company also achieved a 42% Adjusted EBITDA margin for the quarter.

• Total Revenue for Q4 2024 was $194.0 million, an increase of 4% from Q4 2023.
• Contribution ex-TAC for Q4 2024 was $180.2 million, up 9% from Q4 2023.

Mirum Pharmaceuticals reported strong financial performance in Q4 2024, with total revenue reaching $99.4 million and a net loss of $23.79 million. The company also provided positive full-year 2025 guidance, expecting continued revenue growth and positive cash flow.

• Total net product sales for 2024 reached $336.4 million, exceeding expectations.
• The VISTAS study for volixibat in PSC is expected to complete enrollment in the second half of 2025, with topline data anticipated in 2026.

Lemonade achieved its best quarter ever in Q4 2024, driven by accelerating topline growth, stable expenses, and significantly reduced Adjusted EBITDA losses. The company reported strong positive Adjusted Free Cash Flow, marking its first full year of positive Adj. FCF.

• Delivered $27 million in Adjusted Free Cash Flow (Adj. FCF) in Q4 2024, contributing to a full year of positive Adj. FCF at $48 million.
• In Force Premium (IFP) grew 26% year-over-year to $944 million, marking the fifth consecutive quarter of accelerating growth.

MYR Group Inc. reported a decrease in fourth-quarter 2024 revenues and net income compared to the previous year, primarily due to lower revenues from certain clean energy projects in the T&D segment. Despite this, the company saw an overall improvement in performance compared to the third quarter and maintained a healthy backlog, reflecting continued investment in infrastructure.

• Fourth-quarter 2024 revenues decreased by 17.4% to $829.8 million compared to Q4 2023.
• Net income for Q4 2024 was $16.0 million, or $0.99 per diluted share, down from $24.0 million in Q4 2023.

AvidXchange reported a 10.9% increase in total revenue to $115.4 million, GAAP net income of $4.7 million, and non-GAAP net income of $17.3 million. The company's gross profit increased to $78.8 million, and adjusted EBITDA was $26.3 million. Key business metrics included 19.9 million total transactions processed and $21.9 billion in total payment volume.

• Total revenue increased by 10.9% year-over-year to $115.4 million.
• GAAP net income was $4.7 million, a significant improvement from the previous year's net loss of $(4.5) million.

Certara reported strong fourth quarter 2024 results, with total revenue increasing by 14% to $100.4 million and net income reaching $6.6 million, a significant improvement from a net loss in the prior year. The growth was primarily fueled by a 26% increase in software revenue and contributions from Chemaxon.

• Total revenue for Q4 2024 increased by 14% to $100.4 million compared to $88.0 million in Q4 2023.
• Software revenue grew by 26% to $42.3 million in Q4 2024, up from $33.6 million in Q4 2023.

The Vita Coco Company reported a 20% increase in net sales for the fourth quarter, reaching $127 million. Full year net sales increased 5% to $516 million. Net income for the quarter was $3 million, and full year net income increased to $56 million.

• Net sales increased 20% in the fourth quarter to $127 million.
• Vita Coco Coconut Water net sales grew by 30% in the fourth quarter.

Evertec reported strong fourth quarter 2024 results with revenue increasing 11% to $216.4 million and Adjusted EBITDA increasing 24% to $88.6 million. Full year 2024 revenue grew 22% to $845.5 million, and the company completed the acquisitions of Nubity and Grandata.

• Fourth quarter revenue increased 11% to $216.4 million, or approximately 14.5% on a constant currency basis.
• Adjusted EBITDA for the fourth quarter increased 24% to $88.6 million.

VSE Corporation reported strong fourth-quarter 2024 results with a 27% increase in total revenues and a 21% increase in GAAP Net Income, primarily driven by record performance in its Aviation segment. The company also announced strategic transformations, including the acquisition of two commercial aviation aftermarket businesses and the divestiture of its Federal and Defense Services segment.

• Total Revenues increased by 27% to $299.0 million in Q4 2024.
• GAAP Net Income increased by 21% to $15.5 million in Q4 2024.

Marqeta reported a strong fourth quarter for 2024, with Total Processing Volume (TPV) increasing by 29% year-over-year to $80 billion and Gross Profit growing by 18% to $98 million. Net Revenue for the quarter was $136 million, a 14% increase year-over-year. The company also reported a GAAP Net Loss of $27 million and Adjusted EBITDA of $13 million for the quarter.

• Total Processing Volume (TPV) increased by 29% year-over-year to $80 billion in Q4 2024.
• Gross Profit grew by 18% year-over-year to $98 million in Q4 2024, with a gross margin of 72%.

Talos Energy had a strong fourth quarter in 2024, with production of 98.7 MBoe/d and a net loss of $64.5 million. The company successfully drilled the Katmai West #2 well ahead of schedule and under budget, and paid off its credit facility, reducing leverage to 0.8x.

• Production reached 98.7 MBoe/d, with 70% oil and 79% liquids.
• Adjusted EBITDA was $361.8 million.

Geron Corporation reported Q4 2024 financial results, achieving $47.5 million in RYTELO net product revenue and ending the year with a strong cash position. The company expects to reach profitability without additional financing if current sales and operating expense expectations are met. Continued progress in development efforts for relapsed/refractory myelofibrosis could potentially double commercial opportunity.

• Achieved $47.5 million in RYTELO net product revenue in Q4 2024.
• Received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommending approval of RYTELO.

Teladoc Health concluded 2024 with a solid performance in Q4, despite a slight revenue decrease. Integrated Care showed growth and margin expansion, while BetterHelp faced challenges in a difficult operating environment. The company is focused on execution and cost structure improvements for 2025.

• Fourth Quarter 2024 revenue decreased 3% year-over-year to $640.5 million.
• Net loss for Fourth Quarter 2024 was $48.4 million, or $0.28 per share.

Schrödinger delivered a strong performance in Q4 2024, with total revenue reaching $88.3 million, a 19.1% increase year-over-year, driven by robust software revenue growth of 16.0% to $79.7 million and a significant 58% increase in drug discovery revenue to $8.7 million. Despite the revenue growth, the company reported a net loss of $40.2 million for the quarter.

• Total revenue for Q4 2024 increased 19.1% to $88.3 million, compared to $74.1 million in Q4 2023.
• Software revenue for Q4 2024 increased 16.0% to $79.7 million, primarily due to increased hosted revenue from large customers and new multi-year agreements.

Arhaus reported a net revenue of $347 million for the fourth quarter and $1,271 million for the full year. The company's showroom growth reached 103 locations, including 11 new showrooms and 5 strategic relocations. Demand comparable growth was 5.7% in the fourth quarter.

• Net revenue was $347 million in the fourth quarter.
• Gross margin decreased 1.8% to $139 million in the fourth quarter.

MannKind Corporation delivered robust financial results in the fourth quarter of 2024, with total revenues increasing by 31% year-over-year to $76.776 million and net income reaching $7.422 million, a significant improvement from the previous year. The company also reported a non-GAAP net income of $22.952 million.

• Total revenues for Q4 2024 increased by 31% to $76.776 million compared to Q4 2023.
• Net income for Q4 2024 was $7.422 million, a substantial increase from $1.401 million in Q4 2023.

Pebblebrook Hotel Trust reported a net loss of $49.8 million for Q4 2024, but saw positive growth in Same-Property Total RevPAR by 1.8% and Adjusted FFO per diluted share by 5.0% compared to the previous year. The company's Q4 financial highlights exceeded midpoint outlooks, driven by higher Same-Property Total Revenues and Hotel EBITDA, and an unanticipated business interruption income.

• Net loss for Q4 2024 was $49.8 million, compared to $41.9 million in Q4 2023.
• Same-Property Total RevPAR grew by 1.8% in Q4 2024 compared to Q4 2023, driven by strong resort performance.

SJW Group delivered a strong performance in Q4 2024, with operating revenue increasing by 15% to $197.8 million and net income rising by 21% to $22.9 million. Diluted EPS reached $0.68, reflecting robust growth driven by rate increases and higher customer usage.

• Operating revenue increased by 15% to $197.8 million in Q4 2024 compared to the same period last year.
• Net income for Q4 2024 was $22.9 million, a 21% increase from $18.9 million in Q4 2023.

Immunocore reported Q4 2024 financial results, highlighted by $84.1 million in KIMMTRAK net sales. The company progressed its clinical pipeline and expanded into autoimmune diseases, supported by a strong cash position.

• KIMMTRAK Q4 net sales reached $84.1 million, with $310.0 million for the full year 2024.
• Continued KIMMTRAK lifecycle management with Phase 3 trials in additional melanoma indications.

Alphatec Holdings, Inc. achieved a total revenue of $177 million in Q4 2024, demonstrating strong growth in surgical revenue by 28%. The company also reported a GAAP net loss of $33 million and generated $9 million in free cash flow, positioning itself for self-funded growth in the coming years.

• Total revenue for Q4 2024 reached $177 million.
• Surgical revenue grew by 28% in Q4 2024, driven by 19% surgical volume growth and a 7% increase in average revenue per surgery.

LegalZoom delivered a strong performance in Q4 2024, with revenue increasing by 2% year-over-year to $161.7 million and net income rising by 74% to $12.9 million. Adjusted EBITDA also saw significant growth, up 32% to $44.2 million, reflecting improved operating efficiencies. The company's subscription revenue continued its upward trend, contributing to overall growth.

• Total revenue for Q4 2024 increased by 2% year-over-year to $161.7 million.
• Net income for Q4 2024 grew by 74% year-over-year to $12.9 million, with a net income margin of 8%.

TaskUs announced its fiscal fourth-quarter and full-year 2024 results, with Q4 total revenue reaching $274.2 million, a 17.1% year-over-year increase, surpassing the top-end of their guidance. The company also reported a full-year revenue of $995 million, marking a new company record.

• Fourth quarter total revenue of $274.2 million, representing 17.1% year-over-year growth, exceeded guidance by $4.9 million.
• Net Income for the quarter was $8.9 million, with a Net Income margin of 3.2%.

UMH Properties, Inc. reported a 9% increase in total income for Q4 2024, reaching $61.9 million, and a 9% increase for the full year to $240.6 million. Net income attributable to common shareholders for Q4 was $28,000, while full-year net income was $2.5 million. Normalized FFO per diluted share for the full year increased by 8% to $0.93.

• Total Income increased by 9% for both the fourth quarter and the full year ended December 31, 2024.
• Normalized FFO per diluted share for the full year 2024 increased by 8% to $0.93, up from $0.86 in 2023.

Photronics reported first quarter fiscal year 2025 results with revenue of $212.1 million and GAAP net income of $42.9 million, or $0.68 per diluted share. The company observed favorable demand for high-end products in IC and FPD markets, while mature mainstream masks experienced market softness. They remain cautious about 2025, focusing on cost management and product mix optimization.

• Revenue was $212.1 million, a 2% decrease year-over-year.
• GAAP Net income was $42.9 million, or $0.68 per diluted share, compared to $26.2 million, or $0.42 per diluted share in Q1 2024.

Vir Biotechnology reported a net loss of $(104.6) million for Q4 2024, an improvement from $(116.0) million in Q4 2023. Total revenues for the quarter were $12.4 million, down from $16.8 million in the prior year. The company ended the year with $1.10 billion in cash, cash equivalents, and investments, providing a cash runway into mid-2027.

• Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta is on track to begin in the first half of 2025.
• Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA Breakthrough and Fast Track designations, and EMA PRIME and Orphan Drug designations.

U.S. Physical Therapy reported strong financial results for the fourth quarter and full year 2024, with significant increases in net patient revenue and gross profit. The company achieved record quarterly patient volume and expanded its clinic count through strategic acquisitions, despite challenges from Medicare reimbursement reductions.

• Net patient revenue for physical therapy operations increased by 14.2% to $153.8 million in Q4 2024.
• Total patient visits reached a record 1,432,801 in Q4 2024, up 13.0% from the prior year.

Kennedy-Wilson Holdings, Inc. reported a strong fourth quarter and full year 2024, with Q4 GAAP Net Income of $33.1 million compared to a loss in the prior year. Adjusted EBITDA also saw substantial growth, reaching $190.8 million. The company completed over $4 billion in capital deployment for the full year and generated $122 million in cash from asset sales in Q4.

• GAAP Net Income (Loss) to Common Shareholders improved significantly to $33.1 million in Q4 2024 from a loss of $247.8 million in Q4 2023.
• Adjusted EBITDA increased to $190.8 million in Q4 2024 from a loss of $129.4 million in Q4 2023, driven by realized gains on real estate sales and increased investment management fees.

MiMedx Group, Inc. reported strong fourth quarter and full year 2024 results, with net sales growing 7% year-over-year for the quarter to $93 million and Adjusted EBITDA margin at 21% of net sales. The company also generated strong free cash flow, despite challenges in Medicare reimbursement.

• Net sales for Q4 2024 increased by 7% year-over-year to $93 million.
• Adjusted EBITDA for Q4 2024 was $20 million, representing 21% of net sales.

Rush Street Interactive reported a strong fourth quarter in 2024, with revenue increasing by 31% year-over-year to $254.2 million and adjusted EBITDA surging by 166% to $30.6 million. The company also achieved net income of $6.5 million, a significant improvement from a net loss in the prior year.

• Fourth Quarter Revenue increased by 31% year-over-year to $254.2 million.
• Net income for the fourth quarter was $6.5 million, compared to a net loss of $5.5 million in the prior year.

Roots experienced a slight decrease in total sales for Q4 2023, down 2.9% year-over-year, but saw an increase in net income by 12.6%. Gross margin improved significantly, rising to 58.6%.

• Total sales decreased by 2.9% year-over-year to $108.2 million.
• Net income increased by 12.6% to $14.6 million.

CareDx announced a transformative year in 2024, achieving significant revenue growth and a return to profitability. The company reported a 32% year-over-year increase in Q4 revenue to $86.6 million and a 19% increase in full-year revenue to $333.8 million. Net income for Q4 was $87.7 million, a substantial improvement from a net loss in the prior year.

• Fourth quarter revenue increased 32% year-over-year to $86.6 million.
• Testing services revenue grew 37% year-over-year to $63.8 million, with volume increasing 14%.

Taboola announced strong Q4 and full year results, with Q4 revenue reaching $491.0 million and net income of $33.1 million. The company launched Realize, a new performance platform, and expanded its share repurchase authorization by $200 million.

• Q4 revenues increased to $491.0 million compared to $419.8 million year-over-year.
• Net income for Q4 was $33.1 million, a significant increase from $0.0 million in the previous year.

Encore Capital Group reported a net loss of $225.3 million in the fourth quarter of 2024, compared to a net loss of $270.8 million in the same period last year. Global portfolio purchases increased by 69% to $495.1 million, and global collections increased by 21% to $554.6 million. The loss was primarily driven by significant restructuring actions and non-cash charges related to its Cabot business.

• Global portfolio purchases increased by 69% to $495.1 million in Q4 2024.
• Global collections increased by 21% to $554.6 million in Q4 2024.

Innoviva, Inc. delivered an exceptional Q4 2024, with total revenue reaching $91.8 million, up from $85.84 million in the prior year. The company's core royalty platform contributed $62.52 million, while Innoviva Specialty Therapeutics achieved U.S. net product sales of $24.9 million, reflecting a 47% year-over-year growth. Net income for the quarter was $20.332 million, or $0.32 per basic share.

• Core royalty revenue from GSK was $62.52 million for Q4 2024, contributing significantly to overall revenue.
• Innoviva Specialty Therapeutics (IST) achieved U.S. net product sales of $24.9 million in Q4 2024, marking a 47% year-over-year growth.

Janus International Group reported a decrease in revenue for Q4 2024, with a significant drop in net income and adjusted EBITDA compared to the same period in 2023. The company highlighted the acquisition of TMC and investments in new products despite difficult market conditions.

• Revenue decreased by 12.5% to $230.8 million compared to Q4 2023.
• Net income significantly decreased to $0.3 million, or $0.00 per diluted share, compared to $35.8 million, or $0.24 per diluted share, in Q4 2023.

Applied Optoelectronics reported its Q4 and Full Year 2024 financial results. The company saw increasing orders in its datacenter business and a significant increase in its CATV business due to a ramp in orders for 1.8 GHz amplifier products. Revenue growth more than doubled sequentially. The company also received a substantial order for Quantum Bandwidth® networking products from a top North American cable operator.

• Generated a solid quarter, driven by strength in both datacenter and CATV businesses.
• Continued to see increasing orders in the datacenter business and believe we have solid momentum going forward.

XPEL's fourth quarter 2024 results showed a modest revenue increase of 1.9% to $107.5 million, but net income decreased by 25.7% to $8.9 million, and EBITDA fell by 19.3% to $14.3 million. The company's EPS also declined to $0.32 per share.

• Revenue increased by 1.9% to $107.5 million in Q4 2024, with a 10.5% increase excluding China impacts.
• Gross margin was 40.6% in Q4 2024, an improvement from 38.8% in Q4 2023.

BBSI achieved a strong fourth quarter in 2024, with revenues increasing 10% to $304.8 million and net income rising 15% to $16.8 million, or $0.63 per diluted share. This performance was driven by record worksite employee additions, high client retention, and a successful year-end selling season for their healthcare offering.

• Fourth quarter revenues increased 10% to $304.8 million compared to $276.7 million in the prior year.
• Net income for the fourth quarter increased 15% to $16.8 million, or $0.63 per diluted share, up from $14.6 million, or $0.54 per diluted share, in the year-ago quarter.

Innovex Intl Inc. reported a strong fourth quarter, driven by the Dril-Quip and DWS acquisitions. The company is focused on integrating these businesses and realizing synergies, with a goal of achieving EBITDA margins of 25% or greater. A share repurchase program was authorized, providing a new avenue for shareholder returns.

• Revenue increased by 89% year-over-year to $251 million, driven by the Dril-Quip and DWS acquisitions.
• EBITDA margin increased sequentially from 18% to 20% due to strong execution on synergies.

ACM Research reported a strong fourth quarter with revenue reaching $223.5 million, a 31.2% increase year-over-year. The company's operating income saw a significant rise of 88.2%, reaching $44.0 million. Net income attributable to ACM Research, Inc. was $31.1 million, compared to $17.7 million in the same quarter of the previous year. Diluted EPS was reported at $0.46.

• Revenue increased by 31.2% year-over-year to $223.5 million.
• Operating income rose by 88.2% to $44.0 million.

Bloomin' Brands reported a net loss of $(0.93) per share for Q4 2024, but an adjusted EPS of $0.38. Total revenues were $1,096.8 million, down 8.2% compared to Q4 2023. The company completed the sale of 67% of its Brazil operations and provided a full-year 2025 financial outlook.

• Q4 2024 diluted EPS was $(0.93), while adjusted diluted EPS was $0.38.
• Total revenues for Q4 2024 were $1,096.8 million, a decrease of 8.2% compared to Q4 2023.

CommScope reported a 26.6% increase in net sales to $1.17 billion and an 86.9% increase in non-GAAP adjusted EBITDA to $223.1 million for the fourth quarter of 2024. The company's core non-GAAP adjusted EBITDA increased by 68.7% to $240.4 million. Strategic debt refinancing and the sale of the OWN and DAS businesses have strengthened the company's financial position.

• Net sales increased by 26.6% year-over-year to $1.17 billion, driven by growth in all segments.
• GAAP loss from continuing operations was $65.2 million, an improvement compared to the prior year's loss of $414.0 million.

UWM Holdings Corporation reported a net income of $40.6 million for the fourth quarter of 2024, a significant improvement from a net loss in the same period last year. The company achieved a total loan origination volume of $38.7 billion and a total gain margin of 105 basis points for the quarter.

• Total loan origination volume for Q4 2024 was $38.7 billion, compared to $39.5 billion in Q3 2024 and $24.4 billion in Q4 2023.
• Net income for Q4 2024 was $40.6 million, an increase from $31.9 million in Q3 2024 and a significant turnaround from a net loss of $461.0 million in Q4 2023.

Forward Air Corporation reported a consolidated revenue of $633 million for Q4 2024, with income from continuing operations at $76 million. The company achieved over $100 million in annualized cost synergies in the first year following the Omni acquisition, exceeding the previously committed $75 million.

• Consolidated revenue for Q4 2024 was $632.8 million, an 87.0% increase compared to Q4 2023.
• Income from continuing operations for Q4 2024 was $75.8 million, a significant increase from $3.0 million in Q4 2023, favorably impacted by a goodwill impairment adjustment.

Bristow Group Inc. reported a net income of $31.8 million on total revenues of $353.5 million for the quarter ended December 31, 2024. This represents an increase in net income compared to the preceding quarter, despite a slight decrease in total revenues. The company also exceeded its full-year 2024 Adjusted EBITDA outlook.

• Total revenues for Q4 2024 were $353.5 million, a decrease of $11.6 million compared to Q3 2024.
• Net income for Q4 2024 was $31.8 million, an increase of $3.6 million compared to Q3 2024.

Sinclair, Inc. reported a strong close to 2024, with fourth quarter total revenues increasing by 22% to $1,004 million and net income attributable to the Company reaching $176 million, a substantial improvement from a net loss in the prior year. Adjusted EBITDA also saw an impressive 83% increase, reaching $330 million.

• Total revenues increased 22% to $1,004 million compared to $826 million in the prior year period.
• Net income attributable to the Company was $176 million, a significant turnaround from a net loss of $341 million in the prior year period.

AMERISAFE, Inc. reported a net income of $13.194 million for the fourth quarter of 2024, a decrease of 31.2% compared to the same period in 2023. Diluted earnings per share also decreased by 31.0% to $0.69. Net premiums earned saw a modest increase of 1.2% to $66.510 million.

• Net income for Q4 2024 was $13.194 million, a 31.2% decrease from Q4 2023.
• Diluted earnings per share for Q4 2024 was $0.69, down 31.0% from Q4 2023.

National Vision Holdings, Inc. reported a 3.9% increase in net revenue to $437.3 million for Q4 2024, driven by new store sales and adjusted comparable store sales growth. The company's adjusted operating income increased to $3.2 million, reflecting the benefits of transformation initiatives and cost management.

• Net revenue from continuing operations increased by 3.9% to $437.3 million compared to Q4 2023.
• Comparable store sales growth was 2.6%, with Adjusted Comparable Store Sales Growth of 1.5%.

Trinity Capital Inc. announced strong financial results for the fourth quarter of 2024, with total investment income increasing by 48.1% year-over-year and net investment income reaching a record $34.6 million. The company also reported a significant increase in net assets and a healthy return on average equity.

• Total investment income for Q4 2024 was $70.8 million, a 48.1% increase year-over-year.
• Net investment income reached a record $34.6 million, or $0.58 per basic share.

Establishment Labs reported a fourth quarter revenue of $44.5 million, consistent with preannouncement, and a net loss from operations of $18.7 million, which was a 15% reduction compared to the prior year. The company also saw its adjusted EBITDA loss improve by 25% to $13.1 million.

• Fourth quarter revenue reached $44.5 million, aligning with earlier preannouncements.
• Motiva Implants were approved and launched in the U.S., contributing $3.3 million in U.S. revenue for the fourth quarter.

Aris Water Solutions, Inc. delivered a remarkable fourth quarter and a great year in 2024, successfully growing both volumes and profitability. The company achieved Adjusted EBITDA at the top end of its increased guidance and is now focused on increasing shareholder returns by raising its dividend to $0.14 per share, representing a 33% increase. Strategic initiatives include the acquisition of McNeill Ranch for future growth and expansion into broader industrial water treatment markets.

• Produced water volumes grew 7% year-over-year.
• Set a new quarterly record for recycled water volumes, growing 18% sequentially in Q4 2024.

Energy Recovery achieved a 17% increase in revenue to $67.1 million in Q4 2024, reaching the midpoint of its full-year guidance. The company also saw an improvement in gross margin to 70.2% and a 24.3% increase in income from operations, driven by higher revenue and gross margin.

• Revenue increased by 17% to $67.1 million in Q4 2024 compared to Q4 2023.
• Gross margin improved by 110 basis points to 70.2% in Q4 2024, primarily due to manufacturing transformation benefits.

Digimarc's Q4 2024 results showed a decrease in total revenue to $8.7 million from $9.3 million in Q4 2023. The company reported a net loss of $8.6 million, an improvement from $10.6 million in the prior year. Digimarc is prioritizing authentication use cases and aims for positive non-GAAP net income by Q4 2025 and positive free cash flow by fiscal year 2026.

• Total revenue for Q4 2024 decreased to $8.7 million from $9.3 million in Q4 2023.
• Net loss for Q4 2024 improved to $8.6 million or ($0.40) per share, compared to $10.6 million or ($0.52) per share in Q4 2023.

MGP Ingredients reported a 16% decrease in consolidated sales to $180.8 million for the fourth quarter of 2024. Net income decreased to a loss of $42.0 million due to a one-time, non-cash adjustment of $73.8 million. Excluding the impact of the Atchison distillery, consolidated sales decreased by 7%.

• Consolidated sales decreased by 16% to $180.8 million, or 7% excluding the Atchison distillery impact.
• Gross profit decreased by 13% to $74.5 million, with a gross profit margin of 41.2%.

Astec Industries reported record fourth-quarter results, including net sales of $359.0 million, net income of $21.1 million, and adjusted EPS of $1.19. The company's focus on aftermarket, operational excellence, and procurement contributed to the strong performance. They are anticipating further progress in consistent and profitable growth to produce adjusted EBITDA in the range of $105 million to $125 million for the full year 2025.

• Net sales reached a record $359.0 million.
• Net income was reported at $21.1 million, with an adjusted net income of $27.2 million.

Relay Therapeutics reported no revenue for Q4 2024. Cash, cash equivalents, and investments totaled $781.3 million. Net loss was $76.0 million, or $0.45 per share. The company anticipates initiating the Phase 3 ReDiscover-2 trial of RLY-2608 + fulvestrant in mid-2025.

• RLY-2608 breast cancer program continued to advance, driven by positive maturation of the RLY-2608 + fulvestrant doublet dataset.
• Interim data for RLY-2608 + fulvestrant showed 11.4-month median PFS in 2L patients with PI3Kα-mutated, HR+/HER2- advanced breast cancer.

Plymouth Industrial REIT reported a strong fourth quarter with significant net income growth driven by a gain on the sale of real estate. The company also saw an increase in cash rental rates from commenced leases and expanded its borrowing capacity through a new credit facility.

• Net income attributable to common stockholders increased to $146.2 million, or $3.25 per weighted average common share, up from $9.2 million, or $0.20 per weighted average common share in the prior year.
• Core FFO was $0.46 per weighted average common share and units, compared to $0.47 in the prior year.

ADTRAN Holdings, Inc. reported a revenue of $242.9 million for the fourth quarter of 2024, showing a 7% sequential increase and exceeding the mid-point of their outlook. The company achieved a GAAP gross margin of 37.6% and a non-GAAP gross margin of 42.0%. Operating margin improved sequentially on both GAAP and non-GAAP bases, also above the mid-point of outlook. The company reported a GAAP diluted loss per share of $0.58 and non-GAAP diluted earnings per share of $0.00.

• Revenue for Q4 2024 was $242.9 million, up 7% sequentially and above the mid-point of outlook.
• GAAP gross margin was 37.6%, and non-GAAP gross margin was 42.0%.

Montrose Environmental Group achieved record fourth quarter and full year 2024 financial and operating performance, with significant increases in revenue and Adjusted EBITDA. The company's success was attributed to continued demand for environmental expertise and technology, cross-selling, customer retention, improved operating efficiencies, and successful integration of acquisitions.

• Record fourth quarter revenue of $189.1 million, a 14.1% increase year-over-year.
• Record fourth quarter Consolidated Adjusted EBITDA of $27.2 million, up 55.8% from the prior year.

Excelerate Energy delivered record full year financial results in 2024, driven by strong performance in its core regasification business. The company reported significant increases in net income and Adjusted EBITDA for the full year, while fourth quarter results remained largely flat compared to the previous quarter.

• Net Income for the fourth quarter of 2024 was $46.1 million, contributing to a full year net income of $153.0 million.
• Adjusted EBITDA reached $91.6 million for Q4 2024, with the full year Adjusted EBITDA at $348.2 million.

The ODP Corporation announced Q4 2024 results with a revenue of $1.6 billion and GAAP EPS of $0.36. The company is focusing on B2B growth, including a new agreement with a hospitality management company.

• Total sales were $1.6 billion, a 10% decrease compared to the prior year.
• GAAP operating income was $20 million, and net income from continuing operations was $11 million, or $0.36 per diluted share.

NPK International Inc. reported a strong fourth quarter and full year 2024 results, with a focus on site-access and specialty rental solutions after a business streamlining. The company's Q4 revenue increased by 24% and Adjusted EBITDA increased by 35%, driven by record rental revenue and improved gross margin. The company has also introduced financial guidance for the full-year 2025.

• Revenues of $57.5 million, a 24% increase year-over-year.
• Operating income from continuing operations of $11.6 million.

Kura Oncology reported positive topline results from its KOMET-001 registrational trial, achieving its primary endpoint, and announced alignment with the FDA and EMA on key aspects of the KOMET-017 protocol for potential U.S. accelerated approval. The company also reported a significant increase in collaboration revenue due to its partnership with Kyowa Kirin.

• KOMET-001 registrational trial in R/R NPM1-mutant AML achieved its primary endpoint.
• Alignment reached with FDA and EMA on key aspects of the KOMET-017 protocol, including use of MRD-negative CR endpoint for potential U.S. accelerated approval pathway in frontline intensive chemotherapy trial.

Carriage Services announced its Q4 and full-year 2024 results, exceeding full-year guidance for adjusted consolidated EBITDA and adjusted EPS. While Q4 saw a slight decrease in total revenue and net income, the company achieved significant growth in consolidated cemetery preneed sales and improved its leverage ratio. The full year 2024 performance was strong, with total revenue reaching the high end of the guidance range.

• Total revenue for Q4 2024 was $97.7 million, a slight decrease from $98.8 million in Q4 2023.
• Net income for Q4 2024 was $9.9 million, down from $11.6 million in Q4 2023.

The Honest Company achieved record quarterly revenue of $100 million, an 11% increase from the prior year, and expanded its gross margin by 530 basis points to 39%. The company reported a net loss of less than $1 million, an improvement compared to net income of $1 million in the prior year, and positive adjusted EBITDA of $9 million.

• Record quarterly revenue of $100 million, an 11% increase year-over-year.
• Gross margin expanded by 530 basis points to 38.8% due to cost savings and sales volume growth.

LSB Industries reported an increase in net sales for Q4 2024 compared to Q4 2023, reaching $134.9 million. However, the company experienced a net loss of $9.1 million, which was greater than the previous year's net loss, primarily due to significant turnaround costs and one-time non-cash charges. Despite the net loss, Adjusted EBITDA improved significantly to $37.6 million.

• Net sales increased to $134.9 million in Q4 2024 from $132.6 million in Q4 2023.
• The company reported a net loss of $9.1 million in Q4 2024, compared to a net loss of $5.3 million in Q4 2023, impacted by $17.1 million in turnaround costs and $3.1 million in one-time non-cash charges.

Standard BioTools announced its financial results for the fourth quarter and full fiscal year ended December 31, 2024. The company reported a total revenue of $46.7 million for Q4 2024, with a net loss of $34.1 million and an adjusted EBITDA loss of $18.4 million, showing improvements compared to the previous year.

• Full year 2024 pro forma combined revenue reached $175.1 million.
• The company achieved a 17% Full Year reduction in pro forma operating loss and a 33% year-over-year improvement in adjusted EBITDA.

Universal Health Realty Income Trust reported a net income of $4.7 million, or $0.34 per diluted share, for the fourth quarter of 2024, compared to $3.6 million, or $0.26 per diluted share, for the same period in 2023. FFO increased to $11.8 million, or $0.85 per diluted share, from $11.4 million, or $0.82 per diluted share, in the prior year. The company increased its borrowing capacity to $425 million and extended the maturity date to September 30, 2028.

• Net income for Q4 2024 was $4.7 million, or $0.34 per diluted share, up from $3.6 million, or $0.26 per diluted share, in Q4 2023.
• Adjusted net income increased by $836,000, or $0.06 per diluted share, compared to Q4 2023.

Ambac Financial Group, Inc. reported a consolidated net loss of $(548) million for the fourth quarter of 2024, primarily driven by a $(570) million loss on disposal due to the adoption of discontinued operations accounting standards for its legacy business. Despite this, the company saw substantial growth in its P&C operating businesses, with total P&C premium production increasing by 88% to $265 million and Insurance Distribution revenue growing by 257% to $44 million.

• Total P&C premium production grew to $265 million in Q4 2024, an 88% increase over Q4 2023.
• Insurance Distribution ('Cirrata') total revenue increased by 257% to $44 million for the quarter.

Titan International, Inc. experienced a challenging fourth quarter in 2024, with net sales decreasing to $383.6 million from $390.2 million in the comparable prior year period. The company reported a net loss of $3.59 million for the full fiscal year 2024, a significant decline from a net income of $83.71 million in 2023. Despite the downturn, the company highlighted strong free cash flow generation and successful integration of Carlstar as positive aspects for FY 2024.

• Net sales for Q4 2024 decreased by 1.7% to $383.6 million compared to Q4 2023, primarily due to weakened global end customer demand in agricultural and earthmoving/construction segments.
• Gross profit for Q4 2024 was $41.2 million, a significant reduction from $58.3 million in Q4 2023, leading to a gross margin of 10.7%.

Northwest Pipe Company delivered a robust fourth quarter in 2024, with total net sales increasing by 8.6% year-over-year to $119.6 million. This growth was primarily fueled by a strong performance in the Engineered Steel Pressure Pipe (SPP) segment, which saw a 9.9% increase in net sales and a significant rise in gross profit. The company also achieved a record annual gross profit and net income per diluted share for the full year 2024.

• Fourth quarter net sales increased 8.6% year-over-year to $119.6 million.
• SPP segment net sales increased 9.9% to $82.5 million, with a gross margin of 17.9%.

Service Properties Trust (SVC) announced its financial results for the quarter ended December 31, 2024. The full financial results are available on SVC's website.

• SVC is a real estate investment trust with over $11 billion invested in hotels and service-focused retail net lease properties.
• As of December 31, 2024, SVC owned 206 hotels with over 35,000 guest rooms throughout the United States, Puerto Rico, and Canada.

Theravance Biopharma concluded 2024 with record fourth quarter YUPELRI net sales and profitability, achieving a $50 million TRELEGY related sales milestone. The company also made steady progress in its CYPRESS study and ended the quarter with $88 million in cash.

• YUPELRI® (revefenacin) US net sales reached an all-time high of $66.7 million in Q4 2024, a 10% increase year-over-year.
• FY 2024 TRELEGY Net Sales, as reported by GSK, were $3.46 billion, triggering a $50 million milestone payment to Theravance Biopharma.

ClearPoint Neuro, Inc. announced record revenue of $7.8 million for the fourth quarter of 2024, a 14% increase year-over-year, and $31.4 million for the full year, up 31% from 2023. The company also reduced its total 2024 operational cash burn by 35% to $9.0 million.

• Fourth quarter 2024 revenue increased by 14% year-over-year to $7.8 million.
• Full year 2024 revenue reached a record $31.4 million, marking the tenth consecutive year of growth.

SkyWater Technology reported a 5% decrease in Q4 2024 revenue year-over-year to $75.5 million, but a significant increase in gross margin to 25.6% GAAP and 26.6% non-GAAP. The company achieved net income of $1.9 million non-GAAP, a substantial improvement from a net loss in the prior year, and recorded record fiscal year revenue of $342.3 million.

• Q4 2024 revenue decreased by 5% year-over-year to $75.5 million.
• Gross margin significantly increased to 25.6% on a GAAP basis in Q4 2024, up from 15.2% in Q4 2023.

Keros Therapeutics reported a net loss of $46.0 million for the fourth quarter of 2024, an increase from the $40.2 million net loss in the same period last year. Revenue for the quarter was $3.0 million, primarily from a milestone achievement. The company's cash position was strengthened by a $200.0 million upfront payment from a license agreement with Takeda, extending its cash runway into 2029.

• Net loss for Q4 2024 was $46.0 million, compared to $40.2 million for Q4 2023, primarily due to increased R&D efforts.
• Total revenue for Q4 2024 was $3.042 million, significantly up from $0.143 million in Q4 2023, driven by a license revenue milestone.

Chatham Lodging Trust announced strong Q4 2024 results, with RevPAR increasing 4% to $129. GOP margins rose 150 basis points to 40.5%, and Adjusted EBITDA increased to $21.1 million. The company also made progress on asset recycling, selling two hotels for $29 million.

• Portfolio RevPAR increased 4% to $129 compared to Q4 2023.
• GOP margins increased 150 basis points to 40.5% from 39.0% in Q4 2023.

Diamond Hill's Q4 2024 results showed a revenue of $39.121 million, a 16% increase from Q4 2023. However, net income attributable to common shareholders decreased by 46% to $7.392 million, and diluted EPS fell by 43% to $2.73. For the full year 2024, revenue increased by 11% to $151.095 million, and net income attributable to common shareholders saw a slight increase to $43.178 million, with diluted EPS rising by 9% to $15.66.

• Q4 2024 revenue increased by 16% to $39.121 million compared to Q4 2023.
• Net income attributable to common shareholders for Q4 2024 decreased by 46% to $7.392 million.

ZimVie reported fourth quarter 2024 net sales of $111.5 million, a 1.4% decrease from the previous year. Despite this, the company significantly improved its net loss, reducing it to $(9.7) million from $(22.2) million in Q4 2023, and saw an increase in adjusted EBITDA to $18.4 million.

• Fourth quarter 2024 net sales were $111.5 million, a decrease of 1.4% on a reported basis compared to Q4 2023.
• Net loss for Q4 2024 improved significantly to $(9.7) million from $(22.2) million in Q4 2023.

Xperi Inc. announced its fourth quarter and full-year 2024 financial results, highlighting significant expansion in its independent media platform across Smart TV, connected car, and video-over-broadband. Despite a slight year-over-year revenue decline when adjusting for divested businesses, the company achieved a substantial increase in profitability, doubling its Adjusted EBITDA.

• Achieved TiVo OS milestone of over two million activated Smart TVs.
• Sharp Smart TVs Powered by TiVo began production in December and are now available in certain U.S. retail.

NewtekOne, Inc. reported a significant increase in net income and EPS for the fourth quarter of 2024, with net income reaching $18.3 million and EPS at $0.70 basic and $0.69 diluted. The company also saw substantial growth in total assets and loans held for investment, while raising its full-year 2025 earnings forecast.

• Net income increased by 55.6% on a per share basis compared to the previous quarter and 62.8% compared to the same quarter last year.
• Total assets grew by 50.0% from December 31, 2023, reaching $2.1 billion.

Health Catalyst achieved strong performance in Q4 2024, with total revenue reaching $79.6 million and Adjusted EBITDA at $7.9 million, significantly exceeding the previous year's figures. The Technology segment showed notable growth, contributing to the overall positive results.

• Total revenue for Q4 2024 increased by 6% year-over-year to $79.6 million.
• Adjusted EBITDA for Q4 2024 saw a substantial increase of 485% year-over-year, reaching $7.9 million.

Spok Holdings, Inc. announced strong fourth quarter and full year 2024 results, with software operations bookings up 73.2% year-over-year in Q4 and total 2024 software operations bookings up 13.2%. The company also reported an increase in wireless ARPU and a substantial year-end software backlog.

• Software operations bookings in Q4 2024 totaled $7.1 million, a 73.2% increase from Q4 2023.
• Total 2024 software operations bookings reached $34.1 million, up 13.2% from the prior year.

Taysha Gene Therapies reported a net loss of $89.3 million for the full year ended December 31, 2024, an improvement from the $111.6 million net loss in the prior year. The company's TSHA-102 clinical program for Rett syndrome showed continued progress, with high and low doses being generally well tolerated across all treated patients. Research and development expenses increased to $66.0 million, driven by manufacturing and clinical trial activities, while general and administrative expenses decreased slightly.

• TSHA-102 continues to be generally well tolerated across all pediatric, adolescent, and adult patients in both REVEAL trials, with no treatment-related SAEs or DLTs.
• Dosing of all 10 patients in Part A of both REVEAL trials has been completed, and the maturing dataset supports advancement toward a pivotal Part B trial.

Postal Realty Trust, Inc. announced a strong operational year in 2024, driven by successful re-leasing with 3% annual rent escalations and 10-year lease terms. The company reported a fourth-quarter AFFO of $10.6 million and full-year AFFO of $33.7 million, an 8.4% increase from 2023. They also provided 2025 AFFO guidance of $1.20 to $1.22 per diluted share.

• Acquired 63 USPS properties for approximately $30.7 million in Q4 2024.
• Reported Q4 2024 net income attributable to common shareholders of $4.5 million, or $0.17 per diluted share.

eHealth reported strong Q4 2024 results, exceeding expectations with a 27% increase in total revenue to $315.2 million and an 87% increase in GAAP net income to $97.5 million. The company's performance was driven by a 42% growth in Medicare Advantage submissions and a 16% expansion in Medicare unit margin. eHealth ended the year with a record-high commissions receivable balance of $1.0 billion.

• Total Medicare submissions grew by 38% in Q4 2024, with Medicare Advantage submissions increasing by 42% year-over-year.
• Total Medicare approved members increased by 33% year-over-year, driven by a 39% increase in MA approved members.

Beyond Meat achieved its second consecutive quarter of year-over-year net revenue growth, significantly expanded its gross margin, and substantially reduced operating expenses in the fourth quarter of 2024. The company also announced further restructuring initiatives, including a reduction-in-force and suspension of operational activities in China, aiming for an EBITDA-positive run-rate by the end of 2026.

• Net revenues increased by 4.0% year-over-year to $76.7 million in Q4 2024.
• Gross profit improved significantly to $10.0 million (13.1% gross margin) in Q4 2024, compared to a loss of $83.9 million (-113.8% gross margin) in the prior year.

SEACOR Marine reported consolidated operating revenues of $69.8 million for the fourth quarter of 2024, with an operating income of $10.6 million and a net loss of $26.2 million. This represents a significant improvement in operating performance compared to prior quarters of 2024, primarily due to increased fleet utilization and reduced out-of-service days for repairs and drydockings.

• Operating revenues decreased by 4.5% compared to Q4 2023 but increased by 1.3% from Q3 2024.
• Average day rates increased by 4.8% from Q4 2023, remaining flat compared to Q3 2024.

Alector reported a strong fourth quarter in 2024, with collaboration revenue significantly increasing to $54.2 million from $15.2 million in the same period last year. The company also reduced its net loss to $2.1 million, or $0.02 per share, compared to a net loss of $41.4 million, or $0.49 per share, in Q4 2023. Cash, cash equivalents, and investments totaled $413.4 million, providing a runway through 2026.

• Collaboration revenue for Q4 2024 increased significantly to $54.2 million, up from $15.2 million in Q4 2023.
• Net loss for Q4 2024 was $2.1 million, a substantial improvement from a $41.4 million net loss in Q4 2023.

Braemar Hotels & Resorts Inc. reported strong fourth quarter performance with a 1.9% increase in comparable RevPAR for all hotels, reaching $305. The company ended the quarter with substantial cash and cash equivalents, and a net debt to gross assets ratio of 40.8%.

• Comparable RevPAR for all hotels increased 1.9% over the prior year quarter to $305.
• Net loss attributable to common stockholders for the quarter was $(31.1) million or $(0.47) per diluted share.

Stoneridge, Inc. announced its fourth quarter and full-year 2024 financial results, reporting fourth quarter sales of $218.2 million and a net loss of $(6.1) million. The company's adjusted EBITDA for the quarter was $6.0 million. For the full year, sales were $908.3 million with an adjusted EBITDA of $37.9 million.

• Fourth quarter sales were $218.2 million, a decrease from $229.5 million in Q4 2023.
• The company reported a net loss of $(6.1) million for the fourth quarter, with an adjusted net loss of $(5.0) million.

Virgin Galactic announced its financial results for the fourth quarter of 2024, reporting a revenue of $0.4 million and a net loss of $76 million. The decrease in revenue was attributed to the pause in commercial spaceflights, while the improved net loss was primarily due to lower operating expenses. The company is focusing on the production of its new Delta Class SpaceShips, with the first spaceflight planned for summer 2026.

• Revenue for Q4 2024 was $0.4 million, a decrease from $2.8 million in Q4 2023, due to the pause in commercial spaceflights.
• Net loss improved to $76 million in Q4 2024, compared to $104 million in Q4 2023, primarily driven by lower operating expenses.

Everspin Technologies, Inc. reported fourth quarter revenue of $13.2 million, exceeding expectations, and earnings per share at the high end of their guidance range. The company achieved 178 design wins in 2024, indicating strong future growth opportunities.

• Total revenue for Q4 2024 was $13.2 million, compared to $16.7 million in Q4 2023.
• GAAP net income for Q4 2024 was $1.2 million, or $0.05 per diluted share.

Red Robin Gourmet Burgers, Inc. reported a decrease in total revenues for the fiscal fourth quarter of 2024, primarily due to fewer operating weeks compared to the prior year. Despite the revenue decline, the company saw an increase in comparable restaurant revenue and adjusted EBITDA for the quarter, indicating improved operational efficiency.

• Total revenues for Q4 2024 were $285.2 million, a decrease from $309.0 million in Q4 2023, primarily due to fewer operating weeks.
• Comparable restaurant revenue increased by 3.4% excluding the impact of a change in deferred loyalty revenue, and by 1.8% including this impact.

New Mountain Finance Corporation reported net investment income of $0.32 per weighted average share for Q4 2024, with a net asset value of $12.55 per share. The company maintained strong credit performance, with approximately 97% of its portfolio rated green, and reduced its statutory debt/equity to 1.15x. A first quarter 2025 distribution of $0.32 per share was declared.

• Net investment income for Q4 2024 was $34.5 million, or $0.32 per weighted average share.
• Net asset value per share was $12.55 as of December 31, 2024.

Blackstone Secured Lending Fund reported a strong quarter with active deployment and record total investment income. The company's credit performance remained healthy, with minimal non-accruals and a high percentage of first lien senior secured debt portfolio.

• BXSL's portfolio is designed to provide powerful earnings while mitigating risk across different market environments.
• The portfolio has remained well-positioned with healthy underlying credit fundamentals and a low percentage of investments on non-accrual.